Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
AT&T
T
$171B
| $124M | 0.08% |
+4,210,505
| New | +$115M |
|
252
Northrop Grumman
NOC
$83.2B
| $123M | 0.08% |
401,734
-14,606
| -4% | -$4.39M |
|
253
MSC Industrial Direct
MSM
$6.91B
| $123M | 0.08% |
1,275,343
+1,032,259
| +425% | +$86.3M |
|
254
CALL
Gilead Sciences
GILD
$172B
| $123M | 0.07% |
1,716,800
-199,300
| -10% | -$15.1M |
|
255
PayPal
PYPL
$52.7B
| $123M | 0.07% |
1,664,208
+1,518,323
| +1,041% | +$110M |
|
256
Dell
DELL
$317B
| $122M | 0.07% |
5,352,115
+119,115
| +2% | +$2.7M |
|
257
Trinity Industries
TRN
$2.36B
| $122M | 0.07% |
4,524,183
+1,300,381
| +40% | +$32.4M |
|
258
Restaurant Brands International
QSR
$27.1B
| $122M | 0.07% |
1,981,556
-404,588
| -17% | -$25.9M |
|
259
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$40.5B
| $122M | 0.07% |
960,100
+128,700
| +15% | +$16.2M |
|
260
Lear
LEA
$8.32B
| $122M | 0.07% |
687,947
+15,017
| +2% | +$2.64M |
|
261
Edwards Lifesciences
EW
$52.8B
| $121M | 0.07% |
3,227,325
-787,512
| -20% | -$28.9M |
|
262
Devon Energy
DVN
$50.4B
| $121M | 0.07% |
2,923,669
-2,885,820
| -50% | -$109M |
|
263
CALL
Wells Fargo
WFC
$269B
| $121M | 0.07% |
1,989,000
-160,900
| -7% | -$9.09M |
|
264
PUT
Biogen
BIIB
$31B
| $120M | 0.07% |
377,200
+88,200
| +31% | +$28.3M |
|
265
PUT
Lam Research
LRCX
$416B
| $120M | 0.07% |
6,521,000
+4,108,000
| +170% | +$80.7M |
|
266
Huntsman Corp
HUN
$1.81B
| $120M | 0.07% |
3,604,506
+2,471,109
| +218% | +$75.7M |
|
267
PUT
NetEase
NTES
$80.1B
| $120M | 0.07% |
1,736,500
-2,500
| -0.1% | -$156K |
|
|
AVXS
268
DELISTED
AveXis, Inc. Common Stock
AVXS
| $119M | 0.07% |
1,075,964
+79,743
| +8% | +$8M |
|
269
PUT
Intel
INTC
$542B
| $118M | 0.07% |
2,566,200
+618,100
| +32% | +$27M |
|
270
PUT
JD.com
JD
$39.2B
| $118M | 0.07% |
2,852,100
+769,600
| +37% | +$30.3M |
|
271
PUT
SLB Ltd
SLB
$79.8B
| $117M | 0.07% |
1,743,400
+1,007,200
| +137% | +$65.3M |
|
272
DuPont de Nemours
DD
$19.8B
| $116M | 0.07% |
645,881
-526,520
| -45% | -$94.8M |
|
273
PUT
FedEx
FDX
$79.2B
| $116M | 0.07% |
466,200
+139,700
| +43% | +$31.9M |
|
274
PUT
Amgen
AMGN
$225B
| $116M | 0.07% |
666,200
+265,300
| +66% | +$47M |
|
275
The Mosaic Company
MOS
$6.87B
| $115M | 0.07% |
4,491,438
+1,898,682
| +73% | +$43.6M |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.